Company page
Xintela Ab
Xintela AB is a public company based in Sweden, trading under the ticker XINT. The company has a market capitalization of approximately 16.9 million USD. Xintela focuses on developing innovative therapies and technologies in the field of regenerative medicine.
- Ticker
- XINT:OMXSTO
- Asset type
- Stock
- Market cap
- $16.9M
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- OMXSTO
- Currency
- SEK